The transcriptomic toolbox: resources for interpreting large gene expression data within a precision medicine context for metabolic disease atherosclerosis

C Marín de Evsikova, ID Raplee, J Lockhart… - Journal of Personalized …, 2019 - mdpi.com
As one of the most widespread metabolic diseases, atherosclerosis affects nearly everyone
as they age; arteries gradually narrow from plaque accumulation over time reducing …

Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data

A Bijnens, E Lutgens, T Ayoubi, J Kuiper… - … , and vascular biology, 2006 - Am Heart Assoc
During the past 6 years, gene expression profiling of atherosclerosis has been used to
identify genes and pathways relevant in vascular (patho) physiology. This review discusses …

Development and implementation of an integrated preclinical atherosclerosis database

RR Xiang, Y Wang, MM Shuey… - Circulation: Genomic …, 2024 - Am Heart Assoc
BACKGROUND: Basic scientists have used preclinical animal models to explore
mechanisms driving human diseases for decades, resulting in thousands of publications …

[引用][C] Transcriptomics: new targets for diagnosing and treating cardiovascular disease

JE Freedman - Cardiovascular therapeutics, 2008 - Wiley Online Library
Gene expression is altered through transcriptional regulation, and this can be a powerful
tool to determine specifically how transcription factors influence inflammationdependent …

Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular disease

S Tuteja, DJ Rader - Personalized Medicine, 2012 - Taylor & Francis
Cardiovascular disease (CVD) is the leading cause of death in the world. Over the past
decade considerable progress has been made in understanding the genomic basis of …

Transcriptomics as precision medicine to classify in vivo models of dietary-induced atherosclerosis at cellular and molecular levels

A Evsikov, CM de Evsikova - 2018 - preprints.org
The central promise of personalized medicine is individualized treatments that target
molecular mechanisms underlying the physiological changes and symptoms arising from …

Transcriptome profiling in systems vascular medicine

S Xu - Frontiers in pharmacology, 2017 - frontiersin.org
In the post-genomic, big data era, our understanding of vascular diseases has been
deepened by multiple state-of-the-art “–omics” approaches, including genomics …

Atherosclerosis: the path from genomics to therapeutics

DT Miller, PM Ridker, P Libby… - Journal of the American …, 2007 - jacc.org
Recent rapid advances in genomic tools and techniques hold great promise for transforming
the practice of cardiovascular medicine. Resources including the Human Genome Project …

Transcriptomic biomarkers of cardiovascular disease

DM Pedrotty, MP Morley, TP Cappola - Progress in cardiovascular …, 2012 - Elsevier
Transcriptomics is the study of how our genes are regulated and expressed in different
biological settings. Technical advances now enable quantitative assessment of all …

The molecular basis of predicting atherosclerotic cardiovascular disease risk

M Nayor, KJ Brown, RS Vasan - Circulation research, 2021 - Am Heart Assoc
Atherosclerotic cardiovascular disease (ASCVD) proceeds through a series of stages:
initiation, progression (or regression), and complications. By integrating known biology …